🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06394739
Recruiting Observational

RevCore for In Stent Thrombosis

NCT06394739 · tracked via the Priya Life Science USA tracker
Sponsor
Inari Medical
Phase
Observational
Started
2024-09-09
Last updated
2026-09-16

Condition(s) studied

In-stent Thrombosis

Investigational drug(s) / intervention(s)

Thrombectomy

Thrombectomy: RevCore Thrombectomy to treat in-stent thrombosis

Study summary

The purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Age ≥ 18 years 2. Patients with stent age \> 6 weeks 3. Location of thrombosed stents in proximal lower extremity deep vein segments including at least common femoral, external iliac, or common iliac vein 4. RevCore Thrombectomy Catheter must enter vasculature 5. Willing and able to provide informed consent Exclusion Criteria: 1. Exposed stents with broken struts, significantly deformed struts, struts protruding into the vessel 2. Stents not wall apposed 3. Stents compressed to \<10mm 4. Bilateral in-stent thrombosis 5. Congenital anatomic anomalies of the iliac veins 6. Allergy, hypersensitivity, or thrombocytopenia from heparin or iodinated contrast agents, except for mild to moderate contrast allergies for which pretreatment can be used 7. Any contraindication to anticoagulants or antiplatelets that, in the opinion of the Investigator, cannot be medically managed throughout the study period 8. Chronic non-ambulatory status 9. Known hypercoagulable states (e.g. antiphospholipid syndrome) that, in the opinion of the Investigator, cannot be medically managed throughout the study period 10. Inability to secure venous access 11. Subject has any condition for which, in the opinion of the Investigator, participation would not be in the best interest of the subject 12. Current participation in another investigational drug or device treatment study

Primary outcome measure(s)

Trial sites (17)

FacilityCityRegionStatus
Yale University New Haven Connecticut Recruiting
Medstar Health Research Institute Washington D.C. District of Columbia Recruiting
St. Luke's Hospital Boise Boise Idaho Recruiting
University of Maryland Baltimore Maryland Active Not Recruiting
New York University- Langone New York New York Recruiting
Mission Health Asheville North Carolina Recruiting
UH Cleveland Medical Center Cleveland Ohio Recruiting
Ohio State University Columbus Ohio Recruiting
University of Pennsylvania Philadelphia Pennsylvania Recruiting
Thomas Jefferson University Philadelphia Pennsylvania Withdrawn
Allegheny Health Network Research Institute Pittsburgh Pennsylvania Recruiting
Spartanburg Medical Center Spartanburg South Carolina Recruiting
El Paso Cardiology Associates El Paso Texas Recruiting
Baylor Scott & White Research Institute Plano Texas Recruiting
Sentara Norfolk Virginia Recruiting
University of Washington Seattle Washington Recruiting
West Virginia University- Ruby Memorial Morgantown West Virginia Recruiting

More Inari Medical trials in the USA

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06394739 on ClinicalTrials.gov ↗ ← All trials in the USA